A mathematical model of the effects of drug resistance in cancer chemotherapy
暂无分享,去创建一个
[1] G. Bonadonna,et al. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas. , 1977, Cancer treatment reports.
[2] J H Goldie,et al. Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982, Cancer treatment reports.
[3] D Crowther,et al. Blood and neoplastic diseases. Rational approach to the chemotherapy of human malignant disease-II. , 1974, British medical journal.
[4] E J Freireich,et al. Progress and perspectives in the chemotherapy of acute leukemia. , 1965, Advances in chemotherapy.
[5] H. H. Lloyd,et al. Mathematical analysis of cancer chemotherapy. , 1975, Bulletin of mathematical biology.
[6] B. Chabner. Pharmacologic principles of cancer treatment , 1982 .
[7] H. Skipper,et al. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. , 1964, Cancer chemotherapy reports.
[8] N. Shapiro,et al. Tumor growth and chemotherapy: Mathematical methods, computer simulations, and experimental foundations , 1973 .
[9] S. I. Rubinow,et al. A mathematical model of the chemotherapeutic treatment of acute myeloblastic leukemia. , 1976, Biophysical journal.